Metabolite-Specific Echo Planar Imaging for Preclinical Studies with Hyperpolarized 13C-Pyruvate MRI
Authors:
- Sule I. SahinSSSule I. Sahin
- Xiao JiXJXiao Ji
- Shubhangi AgarwalSAShubhangi Agarwal
- Avantika SinhaASAvantika Sinha
- Ivina MaliIMIvina Mali
- Jeremy W. GordonJGJeremy W. Gordon
- Mark MattinglyMMMark Mattingly
- Sukumar SubramaniamSSSukumar Subramaniam
- John KurhanewiczJKJohn Kurhanewicz
- Peder E. Z. LarsonPLPeder E. Z. Larson
- Renuka SriramRSRenuka Sriram
Open Access
- 27 March 2023
- journal article
- research article
- Published by MDPI AG in Tomography
- Vol. 9 (2) , 736-749
Abstract
Metabolite-specific echo-planar imaging (EPI) sequences with spectral–spatial (spsp) excitation are commonly used in clinical hyperpolarized [1-13C]pyruvate studies because of their speed, efficiency, and flexibility. In contrast, preclinical systems typically rely on slower spectroscopic methods, such as chemical shift imaging (CSI). In this study, a 2D spspEPI sequence was developed for use on a preclinical 3T Bruker system and tested on in vivo mice experiments with patient-derived xenograft renal cell carcinoma (RCC) or prostate cancer tissues implanted in the kidney or liver. Compared to spspEPI sequences, CSI were found to have a broader point spread function via simulations and exhibited signal bleeding between vasculature and tumors in vivo. Parameters for the spspEPI sequence were optimized using simulations and verified with in vivo data. The expected lactate SNR and pharmacokinetic modeling accuracy increased with lower pyruvate flip angles (less than 15°), intermediate lactate flip angles (25° to 40°), and temporal resolution of 3 s. Overall SNR was also higher with coarser spatial resolution (4 mm isotropic vs. 2 mm isotropic). Pharmacokinetic modelling used to fit kPL maps showed results consistent with the previous literature and across different sequences and tumor xenografts. This work describes and justifies the pulse design and parameter choices for preclinical spspEPI hyperpolarized 13C-pyruvate studies and shows superior image quality to CSI.Keywords
Funding Information
- National Institutes of Health (U24CA253377, P41EB013598, R01CA249909)
This publication has 28 references indexed in Scilit:
- A regional bolus tracking and real‐time B1 calibration method for hyperpolarized 13C MRIMagnetic Resonance in Medicine, 2018
- Metabolic Imaging of the Human Brain with Hyperpolarized 13C Pyruvate Demonstrates 13C Lactate Production in Brain Tumor PatientsCancer Research, 2018
- High spatiotemporal resolution bSSFP imaging of hyperpolarized [1‐13C]pyruvate and [1‐13C]lactate with spectral suppression of alanine and pyruvate‐hydrateMagnetic Resonance in Medicine, 2018
- Spectrally selective three‐dimensional dynamic balanced steady‐state free precession for hyperpolarized C‐13 metabolic imaging with spectrally selective radiofrequency pulsesMagnetic Resonance in Medicine, 2016
- Apparent rate constant mapping using hyperpolarized [1–13C]pyruvateNMR in Biomedicine, 2014
- Metabolic Imaging of Patients with Prostate Cancer Using Hyperpolarized [1- 13 C]PyruvateScience Translational Medicine, 2013
- Point spread functions of the T2 decay in k-space trajectories with long echo trainMagnetic Resonance Imaging, 2012
- Imaging considerations for in vivo 13C metabolic mapping using hyperpolarized 13C‐pyruvateMagnetic Resonance in Medicine, 2009
- Multiband excitation pulses for hyperpolarized 13C dynamic chemical-shift imagingJournal of Magnetic Resonance, 2008
- Pulse sequence for dynamic volumetric imaging of hyperpolarized metabolic productsJournal of Magnetic Resonance, 2008